A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.
Share:
More In Business
Will Taylor Swift Release a Surprise New Song?
Bryan West, Gannett’s Taylor Swift reporter, recaps the many, many, theories and Easter eggs Swifties are debating as her ‘Eras Tour’ film comes to Disney+.
Why Project Liberty Wants to Fix the Internet
‘Our Biggest Fight’ author and Project Liberty founder Frank McCourt, Jr. explains his problem with the internet – and why this Tiktok bill is just a starting point.
The Broader Market Has ‘Tremendous Opportunity’
Chris McMahon discusses the Fed’s expected rate cuts, the housing market, and why he’s looking at regional bank stocks.
US Inflation Up Again, Although We Probably Don't Have to Tell You That
Consumer prices in the United States picked up last month, a sign that inflation remains a persistent challenge for the Federal Reserve and for President Biden.
The Happiest Place on Earth is Expanding!
Disney is seeking approval from local officials to expand its California theme park offerings over the next four decades.
Salesforce Introduces New A.I. 'Copilot'
Jayesh Govindarajan, head of A.I. at Salesforce, explains the company's new Einstein copilot, plus other ways it is investing in artificial intelligence.
U.S. Department of Defense Requests Budget of $849.8 Billion
The Pentagon is requesting $849.8 billion from the federal government for the next fiscal year.
Altro Wants to Expand Access to Credit
Altro founder and CEO Michael Broughton shares how his company is bringing both expanded credit access and financial wellness to underserved consumers, plus netting early investments from Tinashe, Quavo, and Jay Z’s Marcy Ventures.
Portillo’s Prefers Consistent Value Over Dynamic Pricing
Portillo’s CEO Michael Osanloo discusses the company’s decades of profitability, opening restaurants in new markets, and why it doesn’t need trends like dynamic pricing.
